DK0757717T3 - Papillomavirusvacciner - Google Patents
PapillomavirusvaccinerInfo
- Publication number
- DK0757717T3 DK0757717T3 DK95919820T DK95919820T DK0757717T3 DK 0757717 T3 DK0757717 T3 DK 0757717T3 DK 95919820 T DK95919820 T DK 95919820T DK 95919820 T DK95919820 T DK 95919820T DK 0757717 T3 DK0757717 T3 DK 0757717T3
- Authority
- DK
- Denmark
- Prior art keywords
- papillomavirus
- papillomavirus vaccines
- proteins
- recombinant
- vaccines
- Prior art date
Links
- 229960002566 papillomavirus vaccine Drugs 0.000 title 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 2
- 241001631646 Papillomaviridae Species 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24279494A | 1994-05-16 | 1994-05-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0757717T3 true DK0757717T3 (da) | 2006-09-25 |
Family
ID=22916213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95919820T DK0757717T3 (da) | 1994-05-16 | 1995-05-15 | Papillomavirusvacciner |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0757717B1 (ru) |
| JP (1) | JP3863559B2 (ru) |
| CN (1) | CN1152935A (ru) |
| AT (1) | ATE328068T1 (ru) |
| AU (1) | AU693203B2 (ru) |
| BG (1) | BG100974A (ru) |
| BR (1) | BR9507657A (ru) |
| CA (1) | CA2189882C (ru) |
| CZ (1) | CZ336696A3 (ru) |
| DE (1) | DE69535018T2 (ru) |
| DK (1) | DK0757717T3 (ru) |
| ES (1) | ES2264126T3 (ru) |
| FI (1) | FI119815B (ru) |
| HU (1) | HUT76354A (ru) |
| MX (1) | MXPA96005662A (ru) |
| NO (1) | NO322133B1 (ru) |
| NZ (1) | NZ285941A (ru) |
| PL (1) | PL183781B1 (ru) |
| PT (1) | PT757717E (ru) |
| RO (1) | RO117541B1 (ru) |
| RU (1) | RU2206608C2 (ru) |
| SI (1) | SI0757717T1 (ru) |
| SK (1) | SK147696A3 (ru) |
| WO (1) | WO1995031532A1 (ru) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6153201A (en) * | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
| CA2200582C (en) * | 1994-09-22 | 2007-03-27 | Merck & Co., Inc. | Dna encoding human papillomavirus type 6a |
| AR004464A1 (es) * | 1994-11-14 | 1998-12-16 | Merck Sharp & Dohme | Un metodo para producir una proteina de capside de papilomavirus |
| GB9621091D0 (en) | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| KR20010072470A (ko) * | 1998-08-14 | 2001-07-31 | 폴락 돈나 엘. | 사람 유두종바이러스 바이러스-유사 입자의 정제방법 |
| CZ301212B6 (cs) | 1998-10-16 | 2009-12-09 | Smithkline Beecham Biologicals S. A. | Vakcinacní prostredek |
| AUPP765398A0 (en) * | 1998-12-11 | 1999-01-14 | University Of Queensland, The | Treatment of papillomavirus infections |
| PT1150712E (pt) * | 1999-02-05 | 2008-12-22 | Merck & Co Inc | Formulações para a vacina do vírus do papiloma humano |
| DE10137102A1 (de) | 2001-07-30 | 2003-02-27 | Deutsches Krebsforsch | Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung |
| GB0206360D0 (en) | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| ATE427990T1 (de) | 2002-04-30 | 2009-04-15 | Oncolytics Biotech Inc | Verbesserte reinigungsmethode fur viren |
| US7858098B2 (en) | 2002-12-20 | 2010-12-28 | Glaxosmithkline Biologicals, S.A. | Vaccine |
| MY140664A (en) * | 2003-09-29 | 2010-01-15 | Merck Sharp & Dohme | Optimized expression of hpv 45 l1 in yeast |
| ES2570006T3 (es) * | 2004-09-30 | 2016-05-13 | Bayer Healthcare Llc | Dispositivos y métodos de preparación continua integrada de moléculas biológicas |
| US7901921B2 (en) | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
| US7955603B2 (en) | 2006-09-29 | 2011-06-07 | Ligocyte Pharmaceuticals, Inc. | Norovirus vaccine formulations |
| RU2482189C2 (ru) * | 2007-01-30 | 2013-05-20 | Трансген С.А. | Полипептиды е2 папилломавируса, применяемые для вакцинации |
| KR20170001720A (ko) | 2007-03-14 | 2017-01-04 | 다케다 백신즈 인코포레이티드 | 바이러스 유사 입자 정제 |
| RU2471807C2 (ru) * | 2007-06-26 | 2013-01-10 | Джапан Хелт Сайенсес Фаундейшн | Вакцинный антиген, способный индуцировать перекрестно реагирующее и нейтрализующее антитело против папилломавируса человека с высоким риском |
| US20100266636A1 (en) | 2007-09-18 | 2010-10-21 | Ligocyte Pharmaceuticals, Inc. | Method of conferring a protective immune response to norovirus |
| SG10201601660YA (en) | 2007-09-18 | 2016-04-28 | Takeda Vaccines Inc | Method of conferring a protective immune response to norovirus |
| WO2009076824A1 (zh) * | 2007-11-23 | 2009-06-25 | Shanghai Zerun Biotechnology Co., Ltd. | 人乳头状瘤病毒主要衣壳蛋白l1基因及其用途 |
| JP5852883B2 (ja) * | 2008-08-08 | 2016-02-03 | タケダ ワクチン，インコーポレイテッド | 交差反応性の増強のための複合カプシドアミノ酸配列を含むウイルス様粒子 |
| MX2011013566A (es) * | 2009-06-19 | 2012-06-28 | Eyegene Inc | Vacunas para cancer cervical. |
| CN102234661A (zh) * | 2010-04-23 | 2011-11-09 | 北京生物制品研究所 | 人乳头瘤病毒类病毒颗粒的制备方法和外源蛋白表达盒、表达系统 |
| JP6034798B2 (ja) | 2010-12-02 | 2016-11-30 | オンコリティクス バイオテク，インコーポレーテッド | 液体ウイルス製剤 |
| JP6034797B2 (ja) | 2010-12-02 | 2016-11-30 | オンコリティクス バイオテク，インコーポレーテッド | 凍結乾燥されたウイルス製剤 |
| RU2445357C1 (ru) * | 2011-02-15 | 2012-03-20 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантный штамм дрожжей pichia angusta - продуцент капсидного белка l1 вируса папилломы человека типа 16 |
| RU2445358C1 (ru) * | 2011-02-15 | 2012-03-20 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантный штамм дрожжей pichia angusta - продуцент капсидного белка l1 вируса папилломы человека типа 18 |
| US20120273424A1 (en) * | 2011-04-29 | 2012-11-01 | Oncolytics Biotech Inc. | Methods of purifying viruses using gel permeation chromatography |
| AU2012282658B2 (en) | 2011-07-11 | 2014-11-27 | Takeda Vaccines, Inc. | Parenteral norovirus vaccine formulations |
| AU2012345443B2 (en) * | 2011-12-01 | 2017-10-26 | University Of Cape Town | HPV chimaeric particle |
| CN103215302B (zh) * | 2012-01-21 | 2019-01-15 | 北京安百胜生物科技有限公司 | 用汉逊酵母表达系统产生hpv18 l1蛋白的方法 |
| CN103361377B (zh) * | 2012-03-28 | 2017-12-05 | 北京安百胜生物科技有限公司 | 用汉逊酵母表达系统产生hpv6 l1蛋白的方法 |
| JOP20130186B1 (ar) | 2012-06-22 | 2021-08-17 | Takeda Vaccines Montana Inc | تنقية الجزيئات الشبيهة بالفيروسات |
| CN110423774A (zh) * | 2013-04-26 | 2019-11-08 | 北京安百胜生物科技有限公司 | 用汉逊酵母表达系统产生hpv58 l1蛋白的方法 |
| CN104120089B (zh) * | 2013-04-26 | 2019-09-24 | 北京安百胜生物科技有限公司 | 用汉逊酵母表达系统产生hpv52 l1蛋白的方法 |
| CN104164374B (zh) * | 2013-05-17 | 2019-10-22 | 北京安百胜生物科技有限公司 | 用汉逊酵母表达系统产生hpv31 l1蛋白的方法 |
| CN104673760B (zh) * | 2013-11-29 | 2018-01-02 | 南京赛威信生物医药有限公司 | 一种原核细胞表达类病毒颗粒的纯化方法 |
| RU2546243C1 (ru) * | 2014-02-13 | 2015-04-10 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантная вакцина для профилактики папилломавирусной инфекции человека и способ ее получения |
| RU2546242C1 (ru) * | 2014-02-13 | 2015-04-10 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | РЕКОМБИНАНТНЫЙ ШТАММ ДРОЖЖЕЙ Hansenula polymorpha - ПРОДУЦЕНТ ГЛАВНОГО КАПСИДНОГО БЕЛКА L1 ВИРУСА ПАПИЛЛОМЫ ЧЕЛОВЕКА ТИПА 18 |
| RU2546241C1 (ru) * | 2014-02-13 | 2015-04-10 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | РЕКОМБИНАНТНЫЙ ШТАММ ДРОЖЖЕЙ Hansenula polymorpha - ПРОДУЦЕНТ ГЛАВНОГО КАПСИДНОГО БЕЛКА L1 ВИРУСА ПАПИЛЛОМЫ ЧЕЛОВЕКА ТИПА 16 |
| RU2546240C1 (ru) * | 2014-02-13 | 2015-04-10 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | РЕКОМБИНАНТНЫЙ ШТАММ ДРОЖЖЕЙ Hansenula polymorpha - ПРОДУЦЕНТ ГЛАВНОГО КАПСИДНОГО БЕЛКА L1 ВИРУСА ПАПИЛЛОМЫ ЧЕЛОВЕКА ТИПА 56 |
| EA201790944A1 (ru) * | 2014-12-26 | 2017-11-30 | Айджин, Инк. | Способ получения вирусоподобных частиц папилломавируса человека |
| US10758606B2 (en) * | 2015-09-04 | 2020-09-01 | Inventprise, Llc | VLP stabilized vaccine compositions |
| RU2676160C1 (ru) * | 2018-02-14 | 2018-12-26 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Рекомбинантный штамм дрожжей Hansenula polymorpha - продуцент главного капсидного белка L1 вируса папилломы человека типа 11 |
| RU2681174C1 (ru) * | 2018-07-12 | 2019-03-04 | Закрытое акционерное общество научно-производственная компания "Комбиотех" | Способ получения рекомбинантной вакцины для профилактики папилломавирусной инфекции человека, рекомбинантная вакцина |
| CN116426396B (zh) * | 2023-06-09 | 2023-09-01 | 内蒙古工业大学 | 一株耐硫酸铵酿酒酵母及其筛选方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2586428B1 (fr) * | 1985-08-26 | 1988-11-25 | Pasteur Institut | Polypeptides et anticorps, caracteristiques du papillomavirus et leurs applications au diagnostic in vitro, a la prevention et/ou la lutte contre des infections a papillomavirus |
| DE3625257A1 (de) * | 1986-07-23 | 1988-02-04 | Behringwerke Ag | Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika |
| DE122007000023I1 (de) * | 1991-07-19 | 2007-08-09 | Univ Queensland St Lucia | Impfsstoff gegen Humanes Papillomavirus (typ 18) |
| DE122007000096I1 (de) * | 1992-06-25 | 2008-03-27 | Papillomavirus vakzine | |
| US5437951A (en) * | 1992-09-03 | 1995-08-01 | The United States Of America As Represented By The Department Of Health And Human Services | Self-assembling recombinant papillomavirus capsid proteins |
| DE4332596A1 (de) * | 1993-09-24 | 1995-03-30 | Martin Josef Dr Sapp | Monoklonale Antikörper |
| AUPM566794A0 (en) * | 1994-05-17 | 1994-06-09 | University Of Queensland, The | Process and product |
-
1995
- 1995-05-15 AT AT95919820T patent/ATE328068T1/de active
- 1995-05-15 RU RU96123707/13A patent/RU2206608C2/ru active
- 1995-05-15 CN CN95194158A patent/CN1152935A/zh active Pending
- 1995-05-15 DK DK95919820T patent/DK0757717T3/da active
- 1995-05-15 AU AU25495/95A patent/AU693203B2/en not_active Expired
- 1995-05-15 DE DE69535018T patent/DE69535018T2/de not_active Expired - Lifetime
- 1995-05-15 PT PT95919820T patent/PT757717E/pt unknown
- 1995-05-15 EP EP95919820A patent/EP0757717B1/en not_active Expired - Lifetime
- 1995-05-15 RO RO96-02165A patent/RO117541B1/ro unknown
- 1995-05-15 WO PCT/US1995/006006 patent/WO1995031532A1/en active IP Right Grant
- 1995-05-15 PL PL95317234A patent/PL183781B1/pl unknown
- 1995-05-15 MX MXPA96005662A patent/MXPA96005662A/es active IP Right Grant
- 1995-05-15 SI SI9530726T patent/SI0757717T1/sl unknown
- 1995-05-15 JP JP52980895A patent/JP3863559B2/ja not_active Expired - Lifetime
- 1995-05-15 ES ES95919820T patent/ES2264126T3/es not_active Expired - Lifetime
- 1995-05-15 CA CA002189882A patent/CA2189882C/en not_active Expired - Lifetime
- 1995-05-15 BR BR9507657A patent/BR9507657A/pt not_active Application Discontinuation
- 1995-05-15 HU HU9603155A patent/HUT76354A/hu unknown
- 1995-05-15 CZ CZ963366A patent/CZ336696A3/cs unknown
- 1995-05-15 SK SK1476-96A patent/SK147696A3/sk unknown
- 1995-06-02 NZ NZ285941A patent/NZ285941A/en not_active IP Right Cessation
-
1996
- 1996-11-12 BG BG100974A patent/BG100974A/xx unknown
- 1996-11-15 NO NO19964862A patent/NO322133B1/no not_active IP Right Cessation
- 1996-11-15 FI FI964592A patent/FI119815B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2189882A1 (en) | 1995-11-23 |
| AU693203B2 (en) | 1998-06-25 |
| RO117541B1 (ro) | 2002-04-30 |
| NZ285941A (en) | 1998-05-27 |
| MXPA96005662A (es) | 2004-08-19 |
| CN1152935A (zh) | 1997-06-25 |
| HUT76354A (en) | 1997-08-28 |
| NO322133B1 (no) | 2006-08-21 |
| JP3863559B2 (ja) | 2006-12-27 |
| JPH10500847A (ja) | 1998-01-27 |
| CA2189882C (en) | 2005-09-20 |
| ES2264126T3 (es) | 2006-12-16 |
| RU2206608C2 (ru) | 2003-06-20 |
| CZ336696A3 (en) | 1997-07-16 |
| PL317234A1 (en) | 1997-03-17 |
| ATE328068T1 (de) | 2006-06-15 |
| DE69535018T2 (de) | 2007-02-15 |
| WO1995031532A1 (en) | 1995-11-23 |
| BR9507657A (pt) | 1997-09-09 |
| AU2549595A (en) | 1995-12-05 |
| NO964862D0 (no) | 1996-11-15 |
| EP0757717A1 (en) | 1997-02-12 |
| FI119815B (fi) | 2009-03-31 |
| BG100974A (en) | 1998-04-30 |
| SK147696A3 (en) | 1997-08-06 |
| HU9603155D0 (en) | 1997-01-28 |
| FI964592A (fi) | 1996-11-15 |
| EP0757717B1 (en) | 2006-05-31 |
| FI964592A0 (fi) | 1996-11-15 |
| EP0757717A4 (en) | 1998-04-15 |
| SI0757717T1 (sl) | 2006-08-31 |
| PT757717E (pt) | 2006-09-29 |
| PL183781B1 (pl) | 2002-07-31 |
| DE69535018D1 (de) | 2006-07-06 |
| NO964862L (no) | 1997-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0757717T3 (da) | Papillomavirusvacciner | |
| CY1105963T1 (el) | Συνθεσεις καψομepιδιακου εμβολιου του ιου του θηλωματος και μεθοδοι χρησης | |
| AU1593001A (en) | Recombinant gelatin in vaccines | |
| FR20C1016I1 (ru) | ||
| GEP20084431B (en) | Papilloma virus vaccine | |
| DK0688227T3 (da) | Fremstilling af humant papillomavirus capsidprotein og viruslignende partikler | |
| MY150893A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
| NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
| UA35639C2 (ru) | Способ получения композиции очищенного капсидного белка вируса папилломы человека | |
| DK0817851T3 (da) | DNA, der koder for humant papillomvirus type 18 | |
| AU7237391A (en) | Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine | |
| ATE147100T1 (de) | Ehv-4 glykoprotein vazin | |
| EP0957936A4 (en) | RECOMBINANT PAPILLONAVIRUS VACCINE FORMULATIONS | |
| HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
| AU1814792A (en) | Immunogenic peptides or polypeptides of the bvd virus and related viruses, vaccines incorporating them or expressing them, methods and means of production thereof | |
| NO910331D0 (no) | Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner. |